Health technology assessment to support health benefits package design: a systematic review of economic evaluation evidence in Zambia.
| Autor: | Simangolwa WM; Health Economics and HIV/AIDs Research Division, University of KwaZulu Natal, Durban, South Africa. mukewarren@gmail.com.; Centre for Health Economics Financing and Technology Assessment, Patient and Citizen Involvement in Health, 3739 Kwacha Road, P.O Box 310159, Olympia, Lusaka, Zambia. mukewarren@gmail.com., Govender K; Health Economics and HIV/AIDs Research Division, University of KwaZulu Natal, Durban, South Africa.; College of Law and Management Sciences, University of KwaZulu Natal, Durban, South Africa., Mbonigaba J; College of Law and Management Sciences, University of KwaZulu Natal, Durban, South Africa. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMC health services research [BMC Health Serv Res] 2024 Nov 18; Vol. 24 (1), pp. 1426. Date of Electronic Publication: 2024 Nov 18. |
| DOI: | 10.1186/s12913-024-11914-z |
| Abstrakt: | Background: Health technology assessment uses explicit economic evaluation evidence to support health benefits package design. However, the limited availability of technical expertise, data, and methods has restricted the production of economic evaluation evidence in low- and middle-income countries. Zambia has initiated a roadmap to support its policy of reviewing and implementing its national benefits package. This study characterises economic evaluation evidence to support this process's evidence mapping, synthesis, and appraisal stages. Methods: This systematic review applies deductive analysis and the preferred reporting items for systematic review and meta-analyses. Four databases were searched to identify studies from 1993 that coincided with Zambia's health benefits package reform. Results: A total of 61 studies met the inclusion criteria. Most of the studies were first authored by nonlocal authors, and the number of local-based authors in each study was low. Almost all funding for economic evaluation research was not local, and only a few studies sought local ethical clearance to conduct research. Infectious diseases were the highest disease control priority for the studies, with HIV research having the highest output. Most of the studies were cost-effectiveness studies that utilised trial-based data and a combination of program, published, and unpublished data for analysis. The studies generally utilised direct cost and applied the ingredient-based costing approach. Natural units were predominantly used for outcomes alongside DALYs. Most studies reported using a 3% discount rate for both costs and outcomes, with only a few reporting methods for sensitivity analysis. Conclusion: Economic evaluation evidence in Zambia has increased, revealing limited local research leadership, methodological inconsistencies, and a focus on infectious diseases. These findings are crucial for revising Zambia's benefits package and may guide researchers and decision-makers in improving the transparency and quality of future research. Competing Interests: Declarations Ethics approval and consent to participate Ethics clearance was obtained from ERES Converge in Zambia (Apr-2022–007) and the Humanities and Social Science Research Ethics Committee at the University of KwaZulu Natal in South Africa (REC00004520/2022). Consent for publication Not applicable. Competing Interest The authors declare no competing interests. (© 2024. The Author(s).) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|